How did the Government decide which treatments, conditions, and care settings should be covered under MediShield Life in this review?
This review prioritised the extension of MediShield Life coverage to medical treatments that:
a. Are high-cost and low-incidence, in line with focus of MediShield Life coverage on catastrophic medical episodes which can benefit from risk pooling;
b. Are clinically and cost-effective;
c. Have significant affordability gaps; and/or
d. Can support shifting of care from hospital to outpatient, community or home.
The approach balances between enhancing affordability for patients while keeping premiums affordable for all.
Related questions
How is the scope of benefits determined? What other treatments have been considered for coverage under MediShield Life?
Why is MediShield Life covering treatments such as CTGTPs and high-cost drugs that only benefit a small number of patients?
How did the Government decide what should be covered under MediShield Life in this review?
What are the hospitalisation and outpatient treatment benefits under MediShield Life?
Need more help?
Get in touch